课题基金 / 基金详情

IgE Regulation of Mast Cell Growth and Survival

IgE Regulation of Mast Cell Growth and Survival
IgE 对肥大细胞生长和存活的调节
批准号:
7071776
负责人:
TOSHIAKI KAWAKAMI
金额:
$37.07万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-01 至 2007-05-31

项目摘要

项目成果

TOSHIAKI KAWAKAMI的其他基金

相似基金

相关文献

中文摘要
翻译
高亲和力IgE受体(Fc ε RI)介导的肥大细胞活化被认为是哮喘和其他过敏性疾病的发病机制以及宿主对某些寄生虫的防御的关键。 最近,我们已经发现,小鼠肥大细胞的存活和生长的促进单体IgE结合Fc ε RI。 IgE不促进DNA合成,但抑制生长因子剥夺诱导的细胞凋亡。这种抗细胞凋亡作用与IgE诱导的FcepsilonRI表面表达增加平行发生,但需要IgE的持续存在。 这些和其他数据使我们假设,单体IgE结合Fc ε RI通过抑制细胞凋亡促进肥大细胞生长。 单体IgE结合产生的信号与Fc ε RI交联产生的信号明显不同。 由IgE结合的FcepsilonRI启动的抗凋亡过程涉及p75 NTR的加速降解,p75 NTR是神经生长因子和其他神经营养因子的促凋亡低亲和力受体。 为了扩展这一假设,1)我们将研究单体IgE对啮齿动物和人类肥大细胞和嗜碱性粒细胞的生长和存活的体外作用。 根据我们的数据,IgE对生长促进小鼠肥大细胞的体外分化,我们将研究IgE对在IgE存在下产生的肥大细胞的表型和功能的影响。2)我们将分析在肥大细胞中生长因子剥夺诱导的凋亡过程中,单体IgE干扰p75 NTR介导的信号传导事件的分子机制。 为了将我们的体外观察扩展到体内研究,3)我们将研究IgE对肥大细胞/嗜碱性粒细胞生长和存活的体内作用。 这些拟议的研究不仅有望为肥大细胞生物学的IgE依赖性过程提供新的见解,而且还为旨在使用抗IgE mAb或可溶性FcepsilonRI α降低循环IgE以治疗哮喘和其他过敏性疾病的治疗方法提供理论基础。
英文摘要
High-affinity IgE receptor (FcepsilonRI)-mediated mast cell activation is thought to be critical to the pathogenesis of asthma and other allergic diseases and the host defense against certain parasites. Recently, we have found that mouse mast cell survival and growth are promoted by monomeric IgE binding to FcepsilonRI. Monomeric IgE does not promote DNA synthesis but suppresses the apoptosis induced by growth factor deprivation. This anti-apoptotic effect occurs in parallel with IgE-induced increases in FcepsilonRI surface expression but requires the continuous presence of IgE. These and other data have led us to hypothesize that monomeric IgE binding to FcepsilonRI promotes mast cell growth by suppressing apoptosis. The signal generated by monomeric IgE binding is distinctly different from those generated by FcepsilonRI cross-linking. The anti-apoptotic process initiated by IgE-bound FcepsilonRI involves accelerated degradation of p75NTR, a pro-apoptotic low-affinity receptor for nerve growth factor and other neurotrophins. In order to expand this hypothesis, 1) we will investigate the in vitro effects of monomeric IgE on the growth and survival of rodent and human mast cells and basophils. In light of our data that IgE on the growth facilitates in vitro differentiation of mouse mast cells, we will investigate the IgE effects on the phenotype and functionality of mast cells generated in the presence of IgE. 2) We will analyze the molecular mechanisms by which monomeric IgE interferes with p75NTR-mediated signaling events during the apoptotic process induced by growth factor deprivation in mast cells. To extend our in vitro observations to in vivo studies, 3) we will investigate in vivo effects of IgE on mast cell/basophil growth and survival. These proposed studies are expected not only to shed novel insight into the IgE-dependent process of mast cell biology but also to provide a theoretical basis for the therapeutic approaches aimed at reducing circulating IgE using anti-IgE mAb or soluble FcepsilonRIalpha to the treatment of asthma and other allergic diseases.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jbior.2013.08.001
发表时间: 2013-09
期刊: Advances in biological regulation
影响因子: --
作者: [Kawakami, Toshiaki, Xiao, Wenbin]
通讯作者: Xiao, Wenbin
DOI: 10.1038/jid.2013.250
发表时间: 2013-12
期刊: JOURNAL OF INVESTIGATIVE DERMATOLOGY
影响因子: 6.5
作者: [Ando, Tomoaki, Matsumoto, Kenji, Namiranian, Siavash, Yamashita, Hirotaka, Glatthorn, Haley, Kimura, Miho, Dolan, Brandon R., Lee, James J., Galli, Stephen J., Kawakami, Yuko, Jamora, Colin, Kawakami, Toshiaki]
通讯作者: Kawakami, Toshiaki
A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor.
Src 家族激酶的较小催化活性足以通过高亲和力 IgE 受体最大限度地激活肥大细胞。
DOI: 10.4049/jimmunol.0901590
发表时间: 2010
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Poderycki,Michael, Tomimori,Yoshiaki, Ando,Tomoaki, Xiao,Wenbin, Maeda-Yamamoto,Mari, Sauer,Karsten, Kawakami,Yuko, Kawakami,Toshiaki]
通讯作者: Kawakami,Toshiaki
Crosstalk between FceRI and MAVS signaling pathways in mast cells
  • 批准号:
    10040848
  • 项目类别:
  • 资助金额:
    $27.45万
  • 财政年份:
    2020
  • 负责人:
    TOSHIAKI KAWAKAMI
  • 依托单位:
Histamine-Releasing Factor Oligomers in Food Allergy
  • 批准号:
    10462489
  • 项目类别:
  • 资助金额:
    $63.43万
  • 财政年份:
    2019
  • 负责人:
    TOSHIAKI KAWAKAMI
  • 依托单位:
Histamine-Releasing Factor Oligomers in Food Allergy
  • 批准号:
    10212221
  • 项目类别:
  • 资助金额:
    $63.43万
  • 财政年份:
    2019
  • 负责人:
    TOSHIAKI KAWAKAMI
  • 依托单位:
Interaction of histamine-releasing factor with immunoglobulins in asthma
  • 批准号:
    8766032
  • 项目类别:
  • 资助金额:
    $49.25万
  • 财政年份:
    2014
  • 负责人:
    TOSHIAKI KAWAKAMI
  • 依托单位:
海外基金